Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
Patricia L. M. Dahia(The University of Texas at San Antonio Health Science Center), Tonino Ercolino(Azienda Ospedaliero-Universitaria Careggi), Massimo Mannelli(University of Florence), Rodrigo A. Toledo(Instituto de Salud Carlos III), Giuseppe Opocher(University of Padua), Oliver Gimm(Linköping University), Trisha Dwight(The University of Sydney), Helen V. Firth(Wellcome Sanger Institute), Jean‐Pierre Bayley(Leiden University), Eamonn R. Maher(Aston University), Jenny Welander(Region of Southern Denmark), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Roderick Clifton‐Bligh(The University of Sydney), Diana E. Benn(The University of Sydney), Nelly Burnichon(Inserm), Alberto Cascón(Spanish National Cancer Research Centre), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Carli M.J. Tops(State University of New York)
Cited by 267
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
A cellular census of human lungs identifies novel cell states in health and in asthma
|Nature Medicine|2019|966
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772